NCT06154304View on ClinicalTrials.gov

BE Study of Albuterol Sulfate Inhalation Aerosol 90 mcg Per Actuation in Patients With Stable Mild Asthma

PHASE3CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

December 6, 2023

Primary Completion Date

September 16, 2024

Study Completion Date

November 29, 2024

Conditions

Bronchial Asthma

Interventions

DRUG

Albuterol Sulfate Inhalation Aerosol (90 mcg per actuation)

90 mcg

DRUG

Ventolin HFA 90Mcg/Actuation Inhalation Aerosol_#1

90 mcg

DRUG

Ventolin HFA, 90 Mcg/Inh Inhalation Aerosol_#2

180 mcg

DRUG

Placebo

Trial Locations (1)

97504

Velocity CLinical Research, Medford

All Listed Sponsors

lead

Cipla Ltd.

INDUSTRY

NCT06154304 - BE Study of Albuterol Sulfate Inhalation Aerosol 90 mcg Per Actuation in Patients With Stable Mild Asthma | Biotech Hunter | Biotech Hunter